These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2870895)

  • 21. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of propranolol to 4'-hydroxypropranolol in the rat and in man.
    Nelson WL; Powell ML
    Drug Metab Dispos; 1979; 7(6):351-5. PubMed ID: 43218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases.
    Thompson JA; Hull JE; Norris KJ
    Drug Metab Dispos; 1981; 9(5):466-71. PubMed ID: 6117447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro metabolism of lidoflazine by rat and dog liver fractions.
    Meuldermans W; Lauwers W; Knaeps A; Heykants J
    Arzneimittelforschung; 1977; 27(4):828-32. PubMed ID: 577461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The formation of glutathione conjugate derived from propranolol.
    Sasame HA; Liberato DJ; Gillette JR
    Drug Metab Dispos; 1987; 15(3):349-55. PubMed ID: 2886310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of diltiazem versus cimetidine on propranolol metabolism.
    Tateishi T; Ohashi K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 3,4-catechol derivative of propranolol, a minor dihydroxylated metabolite.
    Nelson WL; Bartels MJ; Bednarski PJ; Zhang S; Messick K; Horng JS; Ruffolo RR
    J Med Chem; 1984 Jul; 27(7):857-61. PubMed ID: 6330358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes.
    Sanins SM; Adams WJ; Kaiser DG; Halstead GW; Baillie TA
    Drug Metab Dispos; 1990; 18(4):527-33. PubMed ID: 1976078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
    Hong PS; Chan KK
    Drug Metab Dispos; 1991; 19(3):568-73. PubMed ID: 1680621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbinolamines, imines, and oxazolidines from fluorinated propranolol analogs. (19)F NMR and mass spectral characterization and evidence for formation as intermediates in cytochrome P450-catalyzed N-dealkylation.
    Upthagrove AL; Nelson WL
    Drug Metab Dispos; 2001 Aug; 29(8):1114-22. PubMed ID: 11454730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures.
    Nelson WL; Shetty HU
    Drug Metab Dispos; 1986; 14(4):506-8. PubMed ID: 2874001
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary bivalent sulfur metabolites of phenanthrene excreted by the rat and guinea pig.
    Lertratanangkoon K; Horning MG; Middleditch BS; Tsang WS; Griffin GW
    Drug Metab Dispos; 1982; 10(6):614-23. PubMed ID: 6130910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man.
    Hooper WD; Treston AM; Jacobsen NW; Dickinson RG; Eadie MJ
    Drug Metab Dispos; 1983; 11(6):607-10. PubMed ID: 6140148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Product inhibition and dose-dependent bioavailability of propranolol in the isolated perfused rat liver preparation.
    Ghabrial H; Nand R; Stead CK; Smallwood RA; Morgan DJ
    J Pharm Sci; 1994 Jul; 83(7):931-6. PubMed ID: 7965671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of felodipine in liver microsomes from rat, dog, and man.
    Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L
    Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of catechol-like and monophenolic metabolites of propranolol by the rat liver 9000G supernatant.
    Tindell GL; Walle T; Knapp DR
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):11-22. PubMed ID: 625580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats.
    Perkins EJ; Cramer JW; Farid NA; Gadberry MG; Jackson DA; Mattiuz EL; O'Bannon DD; Weiss HJ; Wheeler WJ; Wood PG; Cassidy KC
    Drug Metab Dispos; 2003 Nov; 31(11):1382-90. PubMed ID: 14570771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.